This is the current release of the guideline.

The safety data derived from studies of the intravascular use of low osmolality contrast media (LOCM) cannot be translated to endoscopic retrograde cholangiopancreatography (ERCP) in view of their low incidence of serious adverse events with nonvascular use. The evidence is lacking to support LOCM as a method for decreasing ERCP complications.

There is no justification for the routine use of LOCM during ERCP. In patients considered at high risk for contrast media (CM)-related reactions (i.e., those with a prior serious anaphylactoid reaction to intravascular CM), premedication and/or substitution of LOCM may be considered as an option based on the above-mentioned theoretical considerations.

The low frequency of sepsis after adequate biliary and pancreatic drainage at ERCP and the lack of data argue against the practice of routinely adding antibiotics to CM. Additional data are needed regarding the use of antibiotics in contrast media for those disease states in which optimal drainage cannot be accomplished.

None provided

The type of evidence supporting the recommendations is not specifically stated.

Not applicable: The guideline was not adapted from another source.

2005 Oct

American Society for Gastrointestinal Endoscopy - Medical Specialty Society

American Society for Gastrointestinal Endoscopy

Technology Assessment Committee

Committee Members: Daniel Mishkin, MD; Steven Carpenter, MD; Joseph Croffie, MD; Ram Chuttani, MD; James DiSario, MD; Nadeem Hussain, MD; Julia Liu, MD; Lehel Somogyi, MD; William Tierney, MD; Bret T. Petersen, MD (Chair)

Not stated

This is the current release of the guideline.

None available

None available

This NGC summary was completed by ECRI on May 1, 2007.

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.